Advertisement

Infectious Diseases and Management After Cardiac Surgery

  • Antonio Hernandez Conte
  • Elizabeth Behringer
Chapter

Abstract

The development of infectious diseases and/or inflammatory-related complications in postoperative cardiac surgical patient represents a diverse and complex array of clinical scenarios that may impact and complicate the hospital course of this patient population. Infectious diseases are different from other coexisting medical conditions in several respects. First, patients may have coexisting infectious diseases that may impact perioperative care when they come for surgery—these infections may be manifest or occult. Preexisting infectious diseases may be the reason for the surgery or may alter the risks associated with the surgery. Second, every patient undergoing surgery is at risk of acquiring an infectious disease during the perioperative period. Patients undergoing surgery are vulnerable to infection both at the surgical site and where natural defenses are breached, such as the respiratory tract, urinary tract, bloodstream, and sites of invasive monitoring. Acquired infectious diseases can be passed on to other patients and to health professionals in the perioperative period, and healthcare workers themselves may serve as active agents in transmitting infectious diseases to patients.

Keywords

Surgical site infections Sternal wound infections Bloodstream infections Deep sternal wound infections Catheter-related infections Clostridium difficile infection Infectious diseases in post-cardiac transplant recipients Mycobacterium chimaera infection 

Bibliography

  1. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile—associated enteric disease Clostridium difficile–associated colitis. Ann Intern Med. 2006;145:758–64.CrossRefPubMedGoogle Scholar
  2. Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis. 2006;43:322–30.CrossRefPubMedGoogle Scholar
  3. Burgess W, Margolis A, Gibbs S, Duarte RS, Jackson M. Disinfectant susceptibility profiling of glutaraldehyde-resistant nontuberculous mycobacteria. Infect Control Hosp Epidemiol. 2017;38(7):784–91.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Dellinger EP. Prophylactic antibiotics: administration and timing before operation are more important than administration after operation. Clin Infect Dis. 2007;44:929–30.CrossRefGoogle Scholar
  5. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Jea-Benacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM. Surviving sepsis campaign: guidelines for management of severe sepsis and shock. Intensive Care Med. 2008;34:17–60.CrossRefPubMedGoogle Scholar
  6. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352–60.CrossRefPubMedGoogle Scholar
  7. Haller S, Höller C, Jacobshagen A, Hamouda O, Sin MA, Monnet DL, Plachouras D, Eckmanns T. Contamination during production of heater-cooler units by Mycobacterium chimaera potential cause for invasive cardiovascular infections: results of an outbreak investigation in Germany, April 2015 to February 2016. Euro Surveill. 2016;21.  https://doi.org/10.2807/1560-7917.ES.2016.21.17.30215.
  8. Kohler P, Kuster SP, Bloemberg G, Schulthess B, Frank M, Tanner FC, Rössle M, Böni C, Falk V, Wilhelm MJ. Healthcare-associated prosthetic heart valve, aortic vascular graft, and disseminated Mycobacterium chimaera infections subsequent to open heart surgery. Eur Heart J. 2015;36:2745–53.CrossRefPubMedGoogle Scholar
  9. Kubota H, Miyata H, Motomura N, Ono M, Takamoto S, Harii K, Oura N, Hirabayashi S, Kyo S. Deep sternal wound infection after cardiac surgery. J Cardiothorac Surg. 2013;8:132.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Robinson PJ, Billah B, Leder K, Reid CM, Committee AD. Factors associated with deep sternal wound infection and haemorrhage following cardiac surgery in Victoria☆. Interact Cardiovasc Thorac Surg. 2007;6:167–71.CrossRefPubMedGoogle Scholar
  11. Sax H, Bloemberg G, Hasse B, Sommerstein R, Kohler P, Achermann Y, Rössle M, Falk V, Kuster SP, Böttger EC, Weber R. Prolonged outbreak of mycobacterium chimaera infection after open-chest heart surgery. Clin Infect Dis. 2015;61:67–75.CrossRefPubMedGoogle Scholar
  12. Toumpoulis IK, Anagnostopoulos CE, DeRose JJ, Swistel DG. The impact of deep sternal wound infection on long-term survival after coronary artery bypass grafting. Chest. 2005;127:464–71.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Antonio Hernandez Conte
    • 1
    • 2
  • Elizabeth Behringer
    • 3
  1. 1.University of California, IrvineSchool of MedicineOrangeUSA
  2. 2.Department of AnesthesiologyKaiser Permanente Los Angeles Medical CenterLos AngelesUSA
  3. 3.Department of Cardiac Surgical Intensive Care UnitKaiser Permanente Los Angeles Medical CenterLos AngelesUSA

Personalised recommendations